BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30

• Drug Development

  OXiGENE Reports Final Data From Phase 2 FALCON Study of ZYBRESTAT in Non-Small Cell Lung Cancer

  November 4, 2011

   · 

  1 min read
• Pharm Country

  ATCC is Awarded National Cancer Institute Funding to Establish Physical Science-Oncology Centers Bioresource Core Facility

  November 4, 2011

   · 

  1 min read
• Business

  ZIOPHARM, Inc. Reports Third Quarter Financial Results and Highlights

  November 4, 2011

   · 

  1 min read
• Drug Development

  Galena Biopharma Presents Positive NeuVax(TM) Clinical Results at the 26th Annual Meeting of the Society for Immunotherapy of Cancer

  November 4, 2011

   · 

  1 min read
• Biotech Bay

  Onyx Pharmaceuticals, Inc. to Present at Two Upcoming Healthcare Conferences

  November 4, 2011

   · 

  1 min read
• Business

  Warner Chilcott, PLC Reports Operating Results for the Quarter Ended September 30, 2011

  November 4, 2011

   · 

  1 min read
• Business

  Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results

  November 4, 2011

   · 

  8 min read
• Business

  Tekmira Pharmaceuticals Corporation Conference Call and Webcast Advisory: Third Quarter 2011 Operating Results and Corporate Update

  November 4, 2011

   · 

  1 min read
• Business

  AMAG Pharmaceuticals, Inc. Reschedules Third Quarter Financial Results Conference Call to November 4, 2011 at 8:00 a.m. ET

  November 4, 2011

   · 

  1 min read
• Drug Development

  miRagen Therapeutics Publishes Data Demonstrating that Therapeutic Dosing of miR-15 Family Inhibitor Protects Against Ischemic Injury to the Heart

  November 4, 2011

   · 

  1 min read